Atrium Therapeutics shares owned by Basecamp Wealth Advisors
Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Basecamp Wealth Advisors
from 13F filings
Historical chart of Basecamp Wealth Advisors investment in Atrium Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Atrium Therapeutics held by Basecamp Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Atrium Therapeutics by Basecamp Wealth Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $4.7k | 349 | 13.37 |